Cargando…

Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey

BACKGROUND: Morquio A syndrome (or mucopolysaccharidosis IVa) is an ultra-rare multi-organ disease, resulting in significantly impaired functional capacity, mobility and quality of life (QoL). METHODS: This patient-reported outcomes survey evaluated the global burden of Morquio A among adults (≥18 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Hendriksz, Christian J, Lavery, Christine, Coker, Mahmut, Ucar, Sema Kalkan, Jain, Mohit, Bell, Lisa, Lampe, Christina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016149/
https://www.ncbi.nlm.nih.gov/pubmed/24602160
http://dx.doi.org/10.1186/1750-1172-9-32
_version_ 1782315461843615744
author Hendriksz, Christian J
Lavery, Christine
Coker, Mahmut
Ucar, Sema Kalkan
Jain, Mohit
Bell, Lisa
Lampe, Christina
author_facet Hendriksz, Christian J
Lavery, Christine
Coker, Mahmut
Ucar, Sema Kalkan
Jain, Mohit
Bell, Lisa
Lampe, Christina
author_sort Hendriksz, Christian J
collection PubMed
description BACKGROUND: Morquio A syndrome (or mucopolysaccharidosis IVa) is an ultra-rare multi-organ disease, resulting in significantly impaired functional capacity, mobility and quality of life (QoL). METHODS: This patient-reported outcomes survey evaluated the global burden of Morquio A among adults (≥18 years, N = 27) and children (7-17 years, N = 36), including the impact on mobility, QoL, pain and fatigue. QoL was assessed using the general Health-Related Quality of Life (HRQoL) questionnaire (the EuroQol [EQ]-5D-5L). Pain and pain interference with daily activities were assessed using the Brief Pain Inventory Short Form (BPI-SF) in adults and the Adolescent Pediatric Pain Tool (APPT) in children. Fatigue was assessed by questioning the patients on the number of evenings in a week they felt extremely tired. RESULTS: The clinical data showed a wide heterogeneity in clinical manifestations between patients, with the majority of patients showing differing levels of endurance, short stature, bone and joint abnormalities, abnormal gait and eye problems. Mobility was considerably impaired: 44.4% of children and 85.2% of adult patients were using a wheelchair. High wheelchair reliance significantly reduced QoL. This was mainly driven by reduced scores in the Mobility, Self-care, and Usual Activity domains. The HRQoL utility values were 0.846, 0.582 and 0.057 respectively in adults not using a wheelchair, using a wheelchair only when needed and always using a wheelchair; values were 0.534, 0.664 and –0.180 respectively in children. Employed adult patients had a better HRQoL than unemployed patients (HRQoL utility value 0.640 vs. 0.275, respectively). 64% of children and 74% of adult patients had joint pain; fatigue was reported by 69% of children and 63% of adults. Overall, increased mobility was associated with more severe and widespread pain and more fatigue. CONCLUSIONS: The HRQoL of Morquio A patients is mainly driven by the ability to remain independently mobile without becoming wheelchair dependent. Their QoL reduces dramatically if they always have to use their wheelchair. Even a slightly better mobility (wheelchair use only when needed) greatly improves QoL. Maintenance of functional capacity and mobility paired with better pain management are likely to improve QoL.
format Online
Article
Text
id pubmed-4016149
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-40161492014-05-10 Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey Hendriksz, Christian J Lavery, Christine Coker, Mahmut Ucar, Sema Kalkan Jain, Mohit Bell, Lisa Lampe, Christina Orphanet J Rare Dis Research BACKGROUND: Morquio A syndrome (or mucopolysaccharidosis IVa) is an ultra-rare multi-organ disease, resulting in significantly impaired functional capacity, mobility and quality of life (QoL). METHODS: This patient-reported outcomes survey evaluated the global burden of Morquio A among adults (≥18 years, N = 27) and children (7-17 years, N = 36), including the impact on mobility, QoL, pain and fatigue. QoL was assessed using the general Health-Related Quality of Life (HRQoL) questionnaire (the EuroQol [EQ]-5D-5L). Pain and pain interference with daily activities were assessed using the Brief Pain Inventory Short Form (BPI-SF) in adults and the Adolescent Pediatric Pain Tool (APPT) in children. Fatigue was assessed by questioning the patients on the number of evenings in a week they felt extremely tired. RESULTS: The clinical data showed a wide heterogeneity in clinical manifestations between patients, with the majority of patients showing differing levels of endurance, short stature, bone and joint abnormalities, abnormal gait and eye problems. Mobility was considerably impaired: 44.4% of children and 85.2% of adult patients were using a wheelchair. High wheelchair reliance significantly reduced QoL. This was mainly driven by reduced scores in the Mobility, Self-care, and Usual Activity domains. The HRQoL utility values were 0.846, 0.582 and 0.057 respectively in adults not using a wheelchair, using a wheelchair only when needed and always using a wheelchair; values were 0.534, 0.664 and –0.180 respectively in children. Employed adult patients had a better HRQoL than unemployed patients (HRQoL utility value 0.640 vs. 0.275, respectively). 64% of children and 74% of adult patients had joint pain; fatigue was reported by 69% of children and 63% of adults. Overall, increased mobility was associated with more severe and widespread pain and more fatigue. CONCLUSIONS: The HRQoL of Morquio A patients is mainly driven by the ability to remain independently mobile without becoming wheelchair dependent. Their QoL reduces dramatically if they always have to use their wheelchair. Even a slightly better mobility (wheelchair use only when needed) greatly improves QoL. Maintenance of functional capacity and mobility paired with better pain management are likely to improve QoL. BioMed Central 2014-03-07 /pmc/articles/PMC4016149/ /pubmed/24602160 http://dx.doi.org/10.1186/1750-1172-9-32 Text en Copyright © 2014 Hendriksz et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver ( http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Hendriksz, Christian J
Lavery, Christine
Coker, Mahmut
Ucar, Sema Kalkan
Jain, Mohit
Bell, Lisa
Lampe, Christina
Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey
title Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey
title_full Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey
title_fullStr Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey
title_full_unstemmed Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey
title_short Burden of disease in patients with Morquio A syndrome: results from an international patient-reported outcomes survey
title_sort burden of disease in patients with morquio a syndrome: results from an international patient-reported outcomes survey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016149/
https://www.ncbi.nlm.nih.gov/pubmed/24602160
http://dx.doi.org/10.1186/1750-1172-9-32
work_keys_str_mv AT hendrikszchristianj burdenofdiseaseinpatientswithmorquioasyndromeresultsfromaninternationalpatientreportedoutcomessurvey
AT laverychristine burdenofdiseaseinpatientswithmorquioasyndromeresultsfromaninternationalpatientreportedoutcomessurvey
AT cokermahmut burdenofdiseaseinpatientswithmorquioasyndromeresultsfromaninternationalpatientreportedoutcomessurvey
AT ucarsemakalkan burdenofdiseaseinpatientswithmorquioasyndromeresultsfromaninternationalpatientreportedoutcomessurvey
AT jainmohit burdenofdiseaseinpatientswithmorquioasyndromeresultsfromaninternationalpatientreportedoutcomessurvey
AT belllisa burdenofdiseaseinpatientswithmorquioasyndromeresultsfromaninternationalpatientreportedoutcomessurvey
AT lampechristina burdenofdiseaseinpatientswithmorquioasyndromeresultsfromaninternationalpatientreportedoutcomessurvey